Skip to main content
. 2025 Sep 4;13(9):2161. doi: 10.3390/biomedicines13092161
MASLD Metabolic dysfunction-associated steatotic liver disease
MASH Metabolic dysfunction-associated steatohepatitis
WLT Weight loss target
CI Confidence interval
ALT Alanine aminotransferase
MRI Magnetic resonance imaging
MRI-PDFF Magnetic resonance imaging-based proton density fat fraction
LFC Liver fat content
2D-SWE Two-dimensional shear wave elastography
WC Waist circumference
BMI Body mass index
FFA Free fatty acid
FBG Fasting glucose
FINS Fasting insulin
UA Uric acid
HOMA-IR Homeostasis model assessment of insulin resistance
GGT γ-glutamyl transpeptidase
LSM Liver stiffness measurements
MVPA Moderate-vigorous physical activity
LDL Low-density lipoprotein cholesterol
TG Triglyceride